Hi Srinivasan,
I was curious about your statement on criticisms of CombiChem technology. Could you, or anyone else, briefly describe the drawbacks you see in CombiChem? By the way, I think of CombiChem in terms of virtual high-throughput screening, that is, screening combinatorial compound libraries in protein-ligand studies.
Best Regards,
Richard M. Casey, Ph.D.
----------------------------
RMC Software, Inc.
Founder / CSO
912 E. Ridgecrest Road
Fort Collins, CO 80524
USA
Phone: 970-224-0456
Mobile: 970-980-5975
Fax: 970-224-2831
Email: info*rmcsoft.com<mailto:info]^[rmcsoft.com>
Web: www.rmcsoft.com<http://www.rmcsoft.com/>
----------------------------
----- Original Message -----
From: parthi.s a jubilantbiosys.com<mailto:parthi.s- -jubilantbiosys.com>
To: qsar_society(!)accelrys.com<mailto:qsar_society.@.accelrys.com>
Sent: Tuesday, February 24, 2004 8:48 AM
Subject: QSAR - Combi Chem., what it means to you!
NB: Unless you reset the To: line, your reply goes to the entire list ---
Friends:
After so much of criticism on Combi Chem technology, we find people using this technique but with different names. For instance, High-Throughput-Chemistry, Chemogenomics etc. Also we notice that the Pharma companies have their own refined approach in handling Combi Chem technology. I would appreciate if you could share some your thoughts on what it means to you when it is Combinatorial Chemistry.
Thanks and Regards
- Parthi
---------------------------------
Srinivasan Parthiban
Head-Chemoinformatics
Jubilant Biosys Ltd.
450 Twelfth Cross
Mahalakshmipuram
Bangalore 560 086, India
Tel : +91 80 349 5461 to 5465
___________________________
_______________________________________________ qsar_society mailing list qsar_society-,-accelrys.com http://ftp2.accelrys.com/mailman/listinfo/qsar_society
Received on 2004-03-02 - 17:08 GMT
This archive was generated by hypermail 2.2.0 : 2005-11-24 - 10:21 GMT